Literature DB >> 24330248

Letter: biochemical response to combination anti-retroviral therapy in patients with primary biliary cirrhosis.

A L Mason1, A J Montano-Loza, L Saxinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24330248     DOI： 10.1111/apt.12575

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  6 in total

Review 1.  Combination antiretroviral studies for patients with primary biliary cirrhosis.

Authors:  Ellina Lytvyak; Aldo J Montano-Loza; Andrew L Mason
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators.

Authors:  Hai-Chun Zhang; Rong-Fei Hu; Ting Zhu; Ling Tong; Qiu-Qin Zhang
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

3.  Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease - authors' reply.

Authors:  W Wang; S Indik; G K-S Wong; A L Mason
Journal:  Aliment Pharmacol Ther       Date:  2015-03       Impact factor: 8.171

4.  Role of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosis.

Authors:  David Sharon; Andrew L Mason
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

5.  Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease.

Authors:  W Wang; S Indik; S T Wasilenko; A Faschinger; E J Carpenter; Z Tian; Y Zhang; G K-S Wong; A L Mason
Journal:  Aliment Pharmacol Ther       Date:  2014-12-18       Impact factor: 8.171

6.  Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.

Authors:  David Sharon; Min Chen; Guangzhi Zhang; Safwat Girgis; Banu Sis; Don Graham; Chelsea McDougall; Shawn T Wasilenko; Aldo Montano-Loza; Andrew L Mason
Journal:  Liver Int       Date:  2014-10-31       Impact factor: 5.828
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.